vascularpharma.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: * Disallow: /feed Disallow: /wp-admin Disallow: /tag/ Disallow: /category/ Disallow: /author/ Disallow: /wp-content/plugins/ Allow: /wp-content/uploads/ Allow: /wp-content/themes/*.css* Sitemap:
Meta Tags
Title Vascular Pharmaceuticals Diabetes Research
Description Vascular Pharmaceuticals is addressing the complications of Toggle navigation Company Management Team Board of Directors Investors and Partners Vascular Pharmaceuticals is focused on rapidl Clinical Trials Patient
Keywords N/A
Server Information
WebSite vascularpharma faviconvascularpharma.com
Host IP 31.220.4.98
Location Netherlands
Related Websites
Site Rank
More to Explore
vascularpharma.com Valuation
US$902,433
Last updated: 2023-05-19 09:06:54

vascularpharma.com has Semrush global rank of 11,728,636. vascularpharma.com has an estimated worth of US$ 902,433, based on its estimated Ads revenue. vascularpharma.com receives approximately 104,127 unique visitors each day. Its web server is located in Netherlands, with IP address 31.220.4.98. According to SiteAdvisor, vascularpharma.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$902,433
Daily Ads Revenue US$834
Monthly Ads Revenue US$24,991
Yearly Ads Revenue US$299,886
Daily Unique Visitors 6,942
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
vascularpharma.com. A 3600 IP: 31.220.4.98
vascularpharma.com. NS 3600 NS Record: ns1.vascularpharma.com.
vascularpharma.com. NS 3600 NS Record: ns2.vascularpharma.com.
vascularpharma.com. MX 3600 MX Record: 20 mail.vascularpharma.com.
vascularpharma.com. MX 3600 MX Record: 10 mail.vascularpharma.com.
vascularpharma.com. TXT 3600 TXT Record: v=spf1 ip4:176.126.85.168 a mx ~all
HtmlToTextCheckTime:2023-05-19 09:06:54
Toggle navigation Company Management Team Board of Directors Investors and Partners Vascular Pharmaceuticals is focused on rapidl Clinical Trials Patient Clinical Sites Science VPI-2690B Diabetic Nephropathy News and Researches Contact Us Vascular Pharmaceuticals is addressing the complications of diabetes Vascular Pharmaceuticals is pioneering a new approach to treat one of the most common complications of diabetes, diabetic nephropathy. This type of kidney disease affects individuals living with Type 1 and Type 2 diabetes, and there is currently no cure. We aspire to help people with diabetes live longer, healthier lives. Our lead candidate, VPI-2960B, is in Phase 2 clinical trials. Studies conducted in animal models of diabetic nephropathy have shown that VPI-2690B may stop and even reverse the progression of diabetic nephropathy. We are committed to exploring the benefits of this potential breakthrough for diabetics who currently lack effective treatment options. © Vascular
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Wed, 21 Sep 2022 08:26:23 GMT
Content-Type: text/html; charset=UTF-8
Connection: keep-alive
X-Powered-By: PHP/7.2.10
X-Pingback: http://www.vascularpharma.com/xmlrpc.php
Location: http://www.vascularpharma.com/

HTTP/1.1 200 OK
Server: nginx
Date: Wed, 21 Sep 2022 08:26:23 GMT
Content-Type: text/html; charset=UTF-8
Connection: keep-alive
X-Powered-By: PHP/7.2.10
X-Pingback: http://www.vascularpharma.com/xmlrpc.php
Link: ; rel="https://api.w.org/", ; rel=shortlink
vascularpharma.com Whois Information
Domain Name: VASCULARPHARMA.COM
Registry Domain ID: 1575551369_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.webnames.ru
Registrar URL: http://www.webnames.ru
Updated Date: 2022-04-03T05:15:06Z
Creation Date: 2009-11-13T00:35:56Z
Registry Expiry Date: 2023-11-13T00:35:56Z
Registrar: Regtime Ltd.
Registrar IANA ID: 1362
Registrar Abuse Contact Email: abuse@regtime.net
Registrar Abuse Contact Phone: +78463733047
Domain Status: ok https://icann.org/epp#ok
Name Server: NS1.VASCULARPHARMA.COM
Name Server: NS2.VASCULARPHARMA.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-09-21T08:22:53Z <<<